This announcement is a separate document:
昭衍新药关于2023年年度A股权益分派实施后调整回购股份价格上限的公告
Announcement of Joinn Laboratories regarding the adjustment of the repurchase share price limit after the implementation of the A-share equity distribution in 2023.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated